Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study. [PDF]
Lee J, Ahn HY, Heo JS, Kim M, Lee JK.
europepmc +1 more source
Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]
Lumyongsatien M +5 more
europepmc +1 more source
Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]
Lee ACH, Kahaly GJ.
europepmc +1 more source
Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]
Pérez-Moreiras J +3 more
europepmc +1 more source
Graves’ Orbitopathy and Oxidative Stress [PDF]
C. Novembrino +4 more
openaire +3 more sources
Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W +7 more
europepmc +1 more source
The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]
Sevimli N +3 more
europepmc +1 more source
Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]
Wang D +12 more
europepmc +1 more source
Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]
Chen Y +5 more
europepmc +1 more source
Therapeutic targets for fibro-inflammation in Graves' orbitopathy. [PDF]
Kang YJ, Yoon JS.
europepmc +1 more source

